BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1963681)

  • 1. Differentiation of lymph-node metastases by anti-CEA immunoscintigraphy in a patient with follicular thyroid and breast cancer.
    Lind P; Lechner P; Kuttnig M; Klimpfinger M; Langsteger W; Költringer P; Cesnik H; Eber O
    Nuklearmedizin; 1990 Dec; 29(6):278-81. PubMed ID: 1963681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
    Goldenberg DM; Abdel-Nabi H; Sullivan CL; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener WA
    Cancer; 2000 Jul; 89(1):104-15. PubMed ID: 10897007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated CEA in breast cancer patients with overlooked medullary thyroid carcinoma.
    Andry G; Wildschutz T; Chantrain G; Bonnyns M; Dor P
    Eur J Surg Oncol; 1993 Jun; 19(3):305-8. PubMed ID: 8100201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunolymphoscintigraphy with 99mTc-labeled monoclonal antibody (BW 431/26) reacting with carcinoembryonic antigen in breast cancer.
    Kairemo KJ
    Cancer Res; 1990 Feb; 50(3 Suppl):949s-954s. PubMed ID: 2297747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunoscintigraphy in stomach neoplasms with anti-CEA BW 431/26 monoclonal antibodies marked with Tc 99 m].
    González P; Escobar MI; Csendes A; Lillo R; Fodor M; Guzmán G; Baum RP; Massardo T; Gaínza V; Otárola S
    Rev Med Chil; 1991 May; 119(5):572-6. PubMed ID: 1844299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma.
    Sandrock D; Blossey HC; Steinroeder M; Munz DL
    Henry Ford Hosp Med J; 1989; 37(3-4):173-4. PubMed ID: 2576957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
    Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
    J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer.
    Lind P; Smola MG; Lechner P; Ratschek M; Klima G; Költringer P; Steindorfer P; Eber O
    Int J Cancer; 1991 Apr; 47(6):865-9. PubMed ID: 2010229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful immunoscintigraphic tumor detection with technetium 99m marked monoclonal anti-CEA antibodies].
    Baum RP; Lorenz M; Hertel A; Baew-Christow T; Schwarz A; Hör G
    Onkologie; 1989 Aug; 12 Suppl 1():26-9. PubMed ID: 2685692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.
    Galea MH; Athanassiou E; Bell J; Dilks B; Robertson JF; Elston CW; Blamey RW; Ellis IO
    J Pathol; 1991 Nov; 165(3):221-7. PubMed ID: 1722247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer metastasis to intramammary lymph nodes.
    Lindfors KK; Kopans DB; Googe PB; McCarthy KA; Koerner FC; Meyer JE
    AJR Am J Roentgenol; 1986 Jan; 146(1):133-6. PubMed ID: 3000154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
    Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
    Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CEA immunoscintigraphy might be more useful than computed tomography in the preoperative thoracic evaluation of lung cancer. A comparison between planar immunoscintigraphy, single photon emission computed tomography (SPECT), and computed tomography.
    Buccheri G; Biggi A; Ferrigno D; Leone A; Taviani M; Quaranta M
    Chest; 1993 Sep; 104(3):734-42. PubMed ID: 8365283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma.
    Bock E; Becker W; Scheele J; Wolf F
    Nuklearmedizin; 1992 Jun; 31(3):80-3. PubMed ID: 1641359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoscintigraphy with radionuclide-labeled antibodies to carcinoembryonic antigen.
    DeLand FH; Kim EE; Goldenberg DM
    Cancer Res; 1980 Aug; 40(8 Pt 2):2997-3000. PubMed ID: 7397695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of CEA levels and of immunoscintigraphy (using CEA-marked antibodies) for the diagnosis and therapeutic monitoring of breast cancer: apropos of a case].
    Doalto L; Paridaens R; Dodion P; Manil L; Rigo P; Fruhling J
    Acta Clin Belg; 1991; 46(1):42-7. PubMed ID: 1645918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunoscintigraphy with MAb B72.3 for preoperative detection of lymph node metastases of colorectal carcinoma].
    Mörschel M; Bockisch A; Junginger T
    Chirurg; 1995 May; 66(5):503-6. PubMed ID: 7607013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative assessment of axillary lymph node status in patients with breast adenocarcinoma using intravenous 99mtechnetium mAb-170H.82 (Tru-Scint AD).
    Dessureault S; Koven I; Reilly RM; Couture J; Schmocker B; Damani M; Kirsh J; Ichise M; Sidlofsky S; McEwan AJ; Boniface G; Stern H; Gallinger S
    Breast Cancer Res Treat; 1997 Aug; 45(1):29-37. PubMed ID: 9285114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of breast carcinoma and multiple intraductal papillomas: an histological and immunohistochemical investigation.
    Papotti M; Gugliotta P; Ghiringhello B; Bussolati G
    Histopathology; 1984 Nov; 8(6):963-75. PubMed ID: 6098550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology.
    Chen ZL; Wen DR; Coulson WF; Giuliano AE; Cochran AJ
    Dis Markers; 1991; 9(5):239-48. PubMed ID: 1724633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.